Stay updated with breaking news from Andreaf Wainer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bank of New Hampshire reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 8.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,462 shares of the healthcare product maker’s stock after selling 1,020 shares during the period. Bank of New Hampshire’s […]
Bank of New Hampshire reduced its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 8.2% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 11,462 shares of the healthcare product maker’s stock after selling 1,020 shares during the period. Bank of New Hampshire’s […]
Ghe LLC increased its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 1.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 12,547 shares of the healthcare product maker’s stock after acquiring an additional 182 shares during […]
Lyell Wealth Management LP lessened its stake in Abbott Laboratories (NYSE:ABT – Free Report) by 7.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 55,358 shares of the healthcare product maker’s stock after selling 4,635 shares during the quarter. Lyell Wealth Management […]
Abbott Laboratories (NYSE:ABT – Free Report) had its target price trimmed by Barclays from $141.00 to $140.00 in a research report report published on Monday morning, Benzinga reports. The firm currently has an overweight rating on the healthcare product maker’s stock. A number of other equities analysts have also recently issued reports on ABT. Citigroup […]